The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin

Background: We used 2-deoxy-2-[18F] fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate the FDG uptake in patients with advanced and/or metastatic soft tissue sarcoma (STS) undergoing therapy with Ecteinascidin-743 (ET-743, Trabectedin, YondelisTM). Patients and Methods: The pilot...

全面介紹

書目詳細資料
發表在:Marine Drugs
Main Authors: Gerlinde Egerer, Anthony D. Ho, Antonia Dimitrakopoulou-Strauss, Thomas Schmitt, Patrick Wuchter, Bernd Kasper
格式: Article
語言:英语
出版: MDPI AG 2009-07-01
主題:
在線閱讀:http://www.mdpi.com/1660-3397/7/3/331/

相似書籍